Skip to main content
Premium Trial:

Request an Annual Quote

Molecular Devices Leads Strong Week for BCW Index

Shares of Molecular Devices rose 7.1 percent for the five-day trading period ended Tuesday, leading all firms in the BCW Index. All 15 companies in the Index gained ground for the week, though Bruker was the only other firm to eclipse a 5-percent rise for the period.
 
Overall, the Index rose 2.4 percent. In comparison, the Dow Jones Industrial Average and the Nasdaq each gained 1.6 percent for the same period. The Nasdaq Biotech Index was up 1.8 percent.

 
BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(December 5, 2006)
Last
Price
(November 28, 2006)
% change
Agilent A
33.16
32.60
1.7
Applied Biosystems ABI
37.82
36.32
4.1
Beckman BEC
60.55
59.00
2.6
Bio-Rad BIO
81.60
78.96
3.3
Bruker BRKR
8.00
7.59
5.4
GE GE
35.27
35.20
0.2
Invitrogen IVGN
56.90
55.45
2.6
Millipore MIL
69.89
67.95
2.9
Molecular Devices MDCC
22.20
20.72
7.1
PerkinElmer PKI
21.50
21.10
1.9
Qiagen QGEN
14.52
14.24
2.0
Sigma SIAL
77.01
75.96
1.4
Stratagene STGN
7.55
7.40
2.0
Thermo TMO
44.53
43.69
1.9
Waters WAT
49.82
49.43
0.8
BCW Index Average  
41.35
40.37
2.4
The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.